Teva Reports Labelling Error for Ponlimsi (Denosumab) 60mg Injection
Teva UK Limited has identified a labelling error on the Ponlimsi (Denosumab) carton, incorrectly stating 'For application to the skin'.
Asset / Drug
Drug and asset intelligence for Ponlimsi (Denosumab) with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.